← Back to Search

Dental Implant

T3 Short Dental Implants for Toothless Jaw (Magnolia Trial)

N/A
Waitlist Available
Research Sponsored by Zimmer Biomet
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients for whom a decision has already been made to use a dental implant for the restoration of existing partial edentulism in the posterior mandible or maxilla.
Intact buccal table as verified by CBCT or during surgery. If absent, patient should be excluded from enrollment in the study.
Must not have
Patients with current use of non-steroidal anti-inflammatory drugs, bisphosphonates or corticosteroid treatments.
Patients with a history of generalized severe chronic periodontal disease.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 years
Awards & highlights

Summary

This trial will test how safe and effective the T3 short dental implant is when used in the back of the upper and lower jaw.

Who is the study for?
Adults with missing teeth in the back of their mouth who can undergo standard dental procedures. They must have enough bone height and gum tissue for implants, not smoke heavily, and not be on certain medications like anti-inflammatories or steroids. Pregnant individuals or those planning pregnancy soon cannot participate.Check my eligibility
What is being tested?
The study is testing two types of T3 dental implants: a short version and a standard length one. Both will be fitted with prostheses (artificial teeth). The goal is to see how safe and effective the short implant is when placed in the jaw without needing major bone grafting.See study design
What are the potential side effects?
Potential side effects may include discomfort at the implant site, swelling, bruising, bleeding, infection risk increase around the implant area, possible damage to surrounding teeth or blood vessels during surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am already approved for a dental implant in the back part of my upper or lower jaw.
Select...
My jawbone near the cheek is healthy as confirmed by a special X-ray or during surgery.
Select...
I have teeth that align and allow me to chew properly.
Select...
I am physically fit for surgery and recovery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently taking anti-inflammatory drugs, bisphosphonates, or steroids.
Select...
I have a history of severe gum disease.
Select...
I do not have an active infection or severe inflammation in the treatment area.
Select...
I do not have uncontrolled diabetes, heart disease, or severe mental disorders.
Select...
I have had radiation therapy to my head or jaw.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Crestal Bone regression
Secondary outcome measures
Implant integration and survival

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: T3 short implantExperimental Treatment1 Intervention
The short implants are available in lengths of 5mm and 6mm and in diameters of 5mm and 6mm. For study both configurations, T3 short without nano-scale Discrete Crystalline Deposition (non DCD- surface treatment) and T3 short with nano-scale Discrete Crystalline Deposition (with DCD- surface treatment), will be used.
Group II: T3 standard lengthActive Control1 Intervention
The T3 external hex implants available for this study will consist of lengths of 10mm, 11.5mm, 13mm, 15mm, 18mm and diameters of 4mm, 5mm, and 6mm. They have integrated platform switching (medialized implant/abutment junction). For study both configurations, T3 without nano-scale Discrete Crystalline Deposition (non DCD- surface treatment) and T3 with nano-scale Discrete Crystalline Deposition (with DCD- surface treatment), will be used.

Find a Location

Who is running the clinical trial?

Zimmer BiometLead Sponsor
373 Previous Clinical Trials
67,077 Total Patients Enrolled
ZimVieLead Sponsor
24 Previous Clinical Trials
2,139 Total Patients Enrolled
Hai Bo Wen, PhDStudy DirectorZimVie
1 Previous Clinical Trials
140 Total Patients Enrolled

Media Library

T3 Short Dental Implant System (Dental Implant) Clinical Trial Eligibility Overview. Trial Name: NCT04237545 — N/A
Toothless Jaw Research Study Groups: T3 standard length, T3 short implant
Toothless Jaw Clinical Trial 2023: T3 Short Dental Implant System Highlights & Side Effects. Trial Name: NCT04237545 — N/A
T3 Short Dental Implant System (Dental Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04237545 — N/A
Toothless Jaw Patient Testimony for trial: Trial Name: NCT04237545 — N/A
~18 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top